Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Mini Reviews in Medicinal Chemistry
|
February 28, 2015
Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein
Zhuangzhuang Yu, Liwen Zhao, Qi-Dong You
PLOS Digital Health
|
December 2, 2024
Neural network-based arterial diameter estimation from ultrasound data
Zhuangzhuang Yu, Manolis Sifalakis, Borbála Hunyadi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 20, 2022
Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors
Zhenwei Wang, Yan Zhang, Hai Wang, et al.
Journal of Medicinal Chemistry
|
May 31, 2022
Discovery of 1,6-Naphthyridin-2(1<i>H</i>)-one Derivatives as Novel, Potent, and Selective FGFR4 Inhibitors for the Treatment of Hepatocellular Carcinoma
Xiaomeng Zhang, Yazhou Wang, Jianfeng Ji, et al.
European Journal of Medicinal Chemistry
|
May 11, 2020
Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors
Guofeng Xu, Yan Zhang, Hai Wang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Mini Reviews in Medicinal Chemistry
|
February 28, 2015
Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein
Zhuangzhuang Yu, Liwen Zhao, Qi-Dong You
PLOS Digital Health
|
December 2, 2024
Neural network-based arterial diameter estimation from ultrasound data
Zhuangzhuang Yu, Manolis Sifalakis, Borbála Hunyadi, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 20, 2022
Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors
Zhenwei Wang, Yan Zhang, Hai Wang, et al.
Journal of Medicinal Chemistry
|
May 31, 2022
Discovery of 1,6-Naphthyridin-2(1<i>H</i>)-one Derivatives as Novel, Potent, and Selective FGFR4 Inhibitors for the Treatment of Hepatocellular Carcinoma
Xiaomeng Zhang, Yazhou Wang, Jianfeng Ji, et al.
European Journal of Medicinal Chemistry
|
May 11, 2020
Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors
Guofeng Xu, Yan Zhang, Hai Wang, et al.
Page
of 1